
OKUR P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.45
Average-0.4370
Median-0.4450
Minimum-0.5100
Maximum-0.3400
-0.45
Past Month-0.10 (28.57%)
The P/E ratio for OKUR is -0.45 as of Jun 13, 2025. This represents a decrease of -13.46% compared to its 12-month average P/E ratio of -0.52. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
OnKure Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
OnKure Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing OnKure Therapeutics Inc to industry peers.
OnKure Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
OnKure Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing OnKure Therapeutics Inc to industry peers.
OKUR P/E Ratio Insights
See OnKure Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in OKUR
Order type
Buy in
Order amount
Est. shares
0 shares
OKUR P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $2.65 | -0.45 |
May 1, 2025 | $2.50 | -0.35 |
Apr 1, 2025 | $4.26 | -0.59 |
Mar 3, 2025 | $4.83 | -0.42 |
Feb 3, 2025 | $5.89 | -0.48 |
Jan 2, 2025 | $8.52 | -0.51 |
OKUR End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.45 | -11.76% |
2024 | -0.51 | — |
FAQs About OnKure Therapeutics Inc (OKUR) P/E ratio
The latest P/E ratio of OKUR is -0.45, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
OnKure Therapeutics Inc’s last 12-month average P/E ratio is -0.52, compared to its current P/E ratio of -0.45. This reflects a decrease of -13.46%.
OnKure Therapeutics Inc’s current P/E ratio of -0.45 is lower than its last 12-month average P/E of -0.52. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
OnKure Therapeutics Inc’s average P/E ratio over the last 3 years is -0.17. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
OnKure Therapeutics Inc’s average P/E ratio over the last 5 years is -0.1. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.